Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1993 1
1998 2
2002 1
2004 1
2007 1
2008 1
2009 2
2012 1
2020 1
2021 3
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E; TOMMORROW study investigators. Burns DK, et al. Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0. Lancet Neurol. 2021. PMID: 34146512 Clinical Trial.
Development of a clinical global impression scale for fatigue.
Targum SD, Hassman H, Pinho M, Fava M. Targum SD, et al. Among authors: hassman h. J Psychiatr Res. 2012 Mar;46(3):370-4. doi: 10.1016/j.jpsychires.2011.12.001. Epub 2012 Jan 10. J Psychiatr Res. 2012. PMID: 22236834
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.
Cohen EA, Hassman HH, Ereshefsky L, Walling DP, Grindell VM, Keefe RSE, Wyka K, Horan WP. Cohen EA, et al. Among authors: hassman hh. Neuropsychopharmacology. 2021 Mar;46(4):844-850. doi: 10.1038/s41386-020-00911-5. Epub 2020 Nov 26. Neuropsychopharmacology. 2021. PMID: 33244149 Free PMC article. Clinical Trial.
Safety and efficacy of galantamine in subjects with mild cognitive impairment.
Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS; GAL-INT-11/18 Study Group. Winblad B, et al. Neurology. 2008 May 27;70(22):2024-35. doi: 10.1212/01.wnl.0000303815.69777.26. Epub 2008 Mar 5. Neurology. 2008. PMID: 18322263 Clinical Trial.
18 results